Comparison of AI-assisted ECG and clinical risk scores in selecting individuals with type 2 diabetes for screening for asymptomatic heart failure
Early identification of stage B heart failure (SBHF) in individuals with type 2 diabetes mellitus (T2DM) may allow timely initiation of cardioprotective therapies and help prevent progression to symptomatic heart failure. However, cardiovascular risk in T2DM is heterogeneous, and a selection process for echocardi...